We are live on ! Find out more
ACP

Ashfield Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 14.56%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
AUM
$1.21B
AUM Growth
-$30.5M
Cap. Flow
-$74.7M
Cap. Flow %
-6.16%
Top 10 Hldgs %
26.3%
Holding
256
New
11
Increased
57
Reduced
106
Closed
14

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$8.79M
2
ILMN icon
Illumina
ILMN
+$7.76M
3
DHR icon
Danaher
DHR
+$7.59M
4
SBUX icon
Starbucks
SBUX
+$6.51M
5
AAPL icon
Apple
AAPL
+$4.52M

Sector Composition

Rank Sector Weight
1 Technology 18.07%
2 Healthcare 16.17%
3 Consumer Discretionary 13.13%
4 Communication Services 10.6%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
26
Sherwin-Williams
SHW
$80.7B
$14.2M 1.17%
154,056
-15,126
-9% -$1.47M
LKQ icon
27
LKQ Corp
LKQ
$6.69B
$13.9M 1.14%
391,589
-43,408
-10% -$1.51M
JNJ icon
28
Johnson & Johnson
JNJ
$641B
$13.6M 1.12%
114,909
-339
-0.3% -$41.1K
COL
29
DELISTED
Rockwell Collins
COL
$13.2M 1.09%
156,288
-24,200
-13% -$2.04M
CVX icon
30
Chevron
CVX
$378B
$13M 1.07%
126,714
+1,256
+1% +$128K
RACE icon
31
Ferrari
RACE
$66.8B
$12.4M 1.02%
238,718
-27,443
-10% -$1.28M
WBA
32
DELISTED
Walgreens Boots Alliance
WBA
$12.2M 1%
150,876
-11,820
-7% -$964K
BUD icon
33
AB InBev
BUD
$156B
$11.9M 0.98%
90,546
-7,954
-8% -$1.01M
SHPG
34
DELISTED
Shire pic
SHPG
$11.7M 0.97%
60,580
-5,571
-8% -$1.09M
MIDD icon
35
Middleby
MIDD
$6.15B
$11.6M 0.96%
94,096
-12,914
-12% -$1.59M
FTV icon
36
Fortive
FTV
$19.2B
$11.6M 0.96%
+362,090
New +$11.6M
BIIB icon
37
Biogen
BIIB
$29.5B
$11.6M 0.96%
37,124
-2,138
-5% -$633K
TJX icon
38
TJX Companies
TJX
$173B
$11.4M 0.94%
303,584
-31,008
-9% -$1.21M
GE icon
39
GE Aerospace
GE
$375B
$11M 0.91%
77,571
+698
+0.9% +$104K
CRI icon
40
Carter's
CRI
$1.43B
$10.7M 0.88%
123,485
-15,374
-11% -$1.54M
EL icon
41
Estee Lauder
EL
$30.1B
$10.6M 0.87%
119,356
-11,370
-9% -$1.04M
LOW icon
42
Lowe's Companies
LOW
$119B
$10.3M 0.85%
142,171
-15,805
-10% -$1.23M
INTC icon
43
Intel
INTC
$462B
$10.1M 0.83%
266,952
+19,513
+8% +$691K
PG icon
44
Procter & Gamble
PG
$346B
$9.72M 0.8%
108,293
-359
-0.3% -$31.2K
MMM icon
45
3M
MMM
$91.9B
$9.51M 0.78%
64,522
DG icon
46
Dollar General
DG
$27.2B
$9.46M 0.78%
135,236
-12,949
-9% -$1.1M
TSCO icon
47
Tractor Supply
TSCO
$16.7B
$9.23M 0.76%
684,930
+209,200
+44% +$3.48M
LQD icon
48
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
$9.1M 0.75%
73,870
-1,731
-2% -$213K
ALLY icon
49
Ally Financial
ALLY
$13.3B
$8.74M 0.72%
448,938
-71,496
-14% -$1.33M
GILD icon
50
Gilead Sciences
GILD
$162B
$8.15M 0.67%
103,071
-36,232
-26% -$2.94M

Similar funds

Ashfield Capital Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Ashfield Capital Partners held 256 positions worth $1.21B, down 2.5% from $1.24B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ashfield Capital Partners withdrew a net $74.7M in Q3 2016, closing 14 positions and reducing 106 holdings. Its most notable exit was Illumina, an estimated $7.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ashfield Capital Partners opened a new position in Fortive worth $11.6M.

  • Ashfield Capital Partners's largest Q3 2016 buy was Fortive: 362,090 shares worth $11.6M.
  • Ashfield Capital Partners added most to Bright Horizons in Q3 2016, an estimated $5.41M increase.
  • Ashfield Capital Partners's biggest Q3 2016 reduction was Analog Devices, cutting an estimated $8.79M.
  • Ashfield Capital Partners fully exited Illumina in Q3 2016, selling an estimated $7.76M.
  • Ashfield Capital Partners's ten largest holdings make up 26% of its $1.21B portfolio in Q3 2016.
  • Ashfield Capital Partners opened 11 new positions and closed 14 in Q3 2016.
  • Ashfield Capital Partners's portfolio value fell 2.5% quarter-over-quarter to $1.21B.

Based on Ashfield Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.